Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SSBP4 mRNA | affects expression | 17562736
|
C015001 |
arsenite |
arsenite results in decreased expression of SSBP4 mRNA | decreases expression | 18929588
|
C015001 |
arsenite |
TRP53 protein affects the reaction [arsenite results in decreased expression of SSBP4 mRNA] | affects reaction|decreases expression | 18929588
|
D017313 |
Fenretinide |
Fenretinide results in decreased expression of SSBP4 mRNA | decreases expression | 16671099
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SSBP4 mRNA | affects cotreatment|increases expression | 17183730
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SSBP4 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.02 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.30 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
3.17 | 10697514 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.85 | 17688650 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.45 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.86 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.86 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.86 | 20603192 18396377 16609825 18940202 18177632 17507914 18558336 17157402 18985861 17688650 15238991 19232924 18775368 19460635 18316065 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.23 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.61 | 8888407 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.70 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
3.12 | 16601279 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
3.32 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
3.32 | 17159502 16270382 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
3.25 | 16274795 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.77 | 10977129 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
6.02 | 16154183 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.81 | 20734317 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.63 | 15037631 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.69 | 17273769 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 16575769 8888407 17688650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
4.07 | 16109766 11287661 12594235 10663392 12392966 12153990 2444490 16227642 15619225 10915739 12958197 11834606 16081117 18713872 10774834 14725611 12540782 17906064 19923254 19739265 11743745 18071297 14550746 16781746 19085960 11461765 11529661 12705907 17522070 19416960 16177239 19420014 16393943 15968718 19370779 16485898 11421492 19164858 14986274 11739529 17562736 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.07 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.71 | 19426721 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.45 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.64 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.53 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.09 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.91 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.78 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.60 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
9.36 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
9.36 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.50 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.57 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
arsenite |
4.55 | 18296743 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.29 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
4.10 | 16187019 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.41 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.99 | 16870215 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
5.11 | 16612254 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.38 | 15629191 12587719 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 17596541 16294345 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
6.66 | 16707609 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.59 | 18296743 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.69 | 12969438 11587558 19014921 16611625 16610002 12587719 19784758 19460945 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.58 | 17185352 16871587 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.87 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
2.36 | 16809336 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
3.78 | 10697514 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
2.86 | 16270382 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
4.05 | 19513568 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.44 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
4.59 | 16274795 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.40 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.33 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
3.44 | 15958647 17353921 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.95 | 15738583 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.34 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.18 | 18514411 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
6.22 | 16303764 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
3.31 | 16133793 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.69 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
3.45 | 15580305 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.37 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
4.04 | 17024972 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.15 | 12752131 11422049 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.66 | 16303925 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.58 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.96 | 11738929 14763951 1511512 16876388 11044598 15475178 3137016 17978042 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
3.63 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.06 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.15 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.85 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.06 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
3.41 | 16720286 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.13 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.38 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
4.91 | 16154183 |